Lab Result Explanation | Skills Pool
Lab Result Explanation Explain laboratory results for clinicians with clinical context, reference range interpretation, critical value flagging, trending analysis, and diagnostic significance mapping. Use when interpreting lab panels, explaining abnormal results, correlating lab findings with clinical conditions, or generating lab summary reports.
Overview
Provide comprehensive, clinically contextualized explanations of laboratory results including reference range interpretation, critical value identification, result trending over time, inter-test correlations, and diagnostic significance. This skill translates raw lab data into actionable clinical intelligence for healthcare providers, supporting diagnostic reasoning and treatment monitoring.
When to Use
Interpreting comprehensive metabolic panels, CBCs, or specialty lab panels
Explaining abnormal lab results in the context of patient conditions
Identifying critical values requiring immediate clinical action
Trending serial lab results to assess treatment response or disease progression
Correlating lab findings across multiple tests for diagnostic patterns
Generating lab summary reports for clinical handoffs
빠른 설치
Lab Result Explanation npx skillvault add writer/writer-skills-skills-lab-result-explanation-skill-md
스타 3
업데이트 2026. 3. 2.
직업 Test name, value, unit, reference range, specimen date
Patient context Age, sex, diagnoses, medications, renal/hepatic function Structured object
Historical labs Prior results for trending (if available) Array with dates
Clinical question Specific clinical context for interpretation Free text
Lab panel type BMP, CMP, CBC, lipid, hepatic, thyroid, coagulation, etc. String
Methodology
Step 1: Result Classification Classify each lab result:
NORMAL: Within reference range, clinically insignificant
ABNORMAL-LOW: Below reference range
ABNORMAL-HIGH: Above reference range
CRITICAL-LOW: Below critical threshold, immediate action needed
CRITICAL-HIGH: Above critical threshold, immediate action needed
BORDERLINE: Near reference range boundary, clinical judgment needed
Reference Range Adjustments:
Age-adjusted ranges (e.g., creatinine in elderly, alkaline phosphatase in children)
Sex-adjusted ranges (e.g., hemoglobin, creatinine)
Pregnancy-adjusted ranges (e.g., TSH, alkaline phosphatase)
Medication-adjusted interpretation (e.g., INR on warfarin, TSH on levothyroxine)
Step 2: Critical Value Assessment Identify results requiring immediate clinical notification:
Test Critical Low Critical High Potassium Less than 2.5 mEq/L Greater than 6.5 mEq/L Sodium Less than 120 mEq/L Greater than 160 mEq/L Glucose Less than 40 mg/dL Greater than 500 mg/dL Calcium (total) Less than 6.0 mg/dL Greater than 13.0 mg/dL Hemoglobin Less than 7.0 g/dL Greater than 20.0 g/dL Platelets Less than 20K/uL Greater than 1000K/uL INR N/A Greater than 5.0 Troponin N/A Above 99th percentile URL Lactate N/A Greater than 4.0 mmol/L WBC Less than 1.0 K/uL Greater than 30.0 K/uL
Step 3: Clinical Contextualization Map lab abnormalities to the patient's clinical context:
Diagnosis-Lab Correlation:
For each abnormal result, identify the most likely clinical explanation given active diagnoses
Flag unexpected abnormalities that do not fit the clinical picture (potential new findings)
Note medication effects on lab values (e.g., ACEi raising potassium, thiazides lowering sodium)
Identify lab patterns suggestive of specific conditions (e.g., elevated AST:ALT ratio greater than 2:1 suggesting alcoholic liver disease)
Anion gap with BMP results (metabolic acidosis workup)
BUN:Creatinine ratio (pre-renal vs. intrinsic renal)
Albumin correction for calcium (corrected Ca = measured Ca + 0.8 x (4.0 - albumin))
Calculated GFR from creatinine using CKD-EPI equation
Iron studies pattern recognition (iron deficiency vs. anemia of chronic disease vs. hemochromatosis)
Step 4: Trend Analysis When historical labs are available, analyze trends:
Direction: rising, falling, stable, fluctuating
Rate of change: rapid, gradual, expected for clinical context
Clinical significance: trending toward or away from critical thresholds
Treatment response: improving toward target or worsening despite treatment
Significant improvement (moving toward normal)
Stable abnormality (consistently out of range, chronic condition)
Worsening trend (moving away from normal)
Acute change (sudden significant shift from baseline)
Step 5: Explanation Generation Produce the lab explanation tailored to the clinical audience:
For each abnormal result, provide:
What the test measures (brief)
What the result means clinically in this patient context
Most likely explanation given diagnoses and medications
Clinical significance and urgency level
Recommended follow-up testing or actions
If trending: direction and clinical implications of the trend
Output Specification lab_panel_summary : panel_type, collection_date, overall_assessment (normal/mixed/significantly abnormal)
results (for each test): test_name, loinc_code, value, unit, reference_range, status (normal/abnormal-low/abnormal-high/critical), clinical_explanation, likely_etiology, related_diagnoses, medication_effects, recommended_action
critical_values : list of critical results requiring immediate notification with urgency_level and recommended_immediate_action
patterns_identified : pattern_name, involved_tests, clinical_significance, suggested_diagnosis_or_condition
trends (if historical data available): test_name, current_value, prior_values with dates, trend_direction, rate_of_change, clinical_interpretation
follow_up_recommendations : recommended_tests, rationale, timing, clinical_priority
Analysis Framework
Common Lab Panel Interpretive Patterns Pattern Key Findings Suggests Pre-renal azotemia BUN:Cr ratio greater than 20:1 Dehydration, CHF, GI bleed Hepatocellular injury AST/ALT elevated, Alk Phos normal Hepatitis, drug toxicity, ischemia Cholestatic pattern Alk Phos/GGT elevated, AST/ALT mildly elevated Biliary obstruction, infiltrative disease DIC Low platelets, elevated PT/PTT, low fibrinogen, elevated D-dimer Disseminated intravascular coagulation Iron deficiency Low iron, low ferritin, high TIBC, low transferrin sat Iron deficiency anemia Tumor lysis High K+, high phosphorus, high uric acid, low calcium Cell lysis from chemotherapy SIADH Low sodium, low serum osmolality, high urine osmolality Inappropriate ADH secretion
eGFR Staging (CKD-EPI 2021) Stage eGFR (mL/min/1.73m2) Description G1 90 or greater Normal or high G2 60-89 Mildly decreased G3a 45-59 Mildly to moderately decreased G3b 30-44 Moderately to severely decreased G4 15-29 Severely decreased G5 Less than 15 Kidney failure
Examples Input : CMP results for 68-year-old male with DM2, CHF, on lisinopril and furosemide. Na 131, K 5.8, BUN 45, Cr 2.1 (baseline 1.4), Glucose 210, CO2 18, Ca 8.2, Albumin 2.8.
Explanation (abbreviated) :
CRITICAL: K+ 5.8 — hyperkalemia likely multifactorial (ACEi + worsening renal function). Immediate EKG needed. Consider holding lisinopril, kayexalate, recheck in 2 hours
Cr 2.1 (baseline 1.4): Acute kidney injury, likely pre-renal given CHF context. BUN:Cr ratio 21:1 supports pre-renal etiology. Assess volume status, consider holding/reducing furosemide
Na 131: Mild hyponatremia, likely hypervolemic in CHF context. Fluid restriction
CO2 18: Low, non-anion-gap metabolic acidosis, consistent with renal tubular acidosis in AKI
Ca corrected: 8.2 + 0.8 x (4.0 - 2.8) = 9.16 — corrected calcium is normal
Glucose 210: Uncontrolled, assess medication adherence, consider adjustment when renal function stabilizes
Guidelines
Always flag critical values prominently — these require immediate clinical actionContextualize, do not just report — raw abnormal flags without context are not clinically usefulAccount for medication effects — many abnormalities are expected consequences of treatmentCalculate derived values — anion gap, corrected calcium, eGFR, BUN:Cr ratioCorrelate across panels — patterns spanning multiple tests are more informative than isolated values
Validation Checklist
HIPAA Compliance Notes
Lab results are PHI and must be handled with appropriate access controls
Lab explanation reports stored or transmitted must be encrypted (AES-256 at rest, TLS 1.2+ in transit)
De-identify lab data used for educational or research purposes
Critical value notifications must follow institutional notification policies and CLIA regulations
Patient access to their own lab results is required under HIPAA and 21st Century Cures Act information blocking rules
When to Use